Literature DB >> 17585917

Reduced plasma adiponectin and elevated leptin in pre-eclampsia.

Yanqiong Ouyang1, Hanping Chen, Huizhen Chen.   

Abstract

OBJECTIVE: To clarify the role of adipocytokine, adiponectin, and leptin in the pathogenesis of pre-eclampsia (PE) and determine the relationships between plasma adiponectin and leptin levels.
METHOD: A total of 73 women in the third trimester of pregnancy were recruited, 53 women with PE (study patients) and 20 age- and BMI-matched normotensive women (healthy controls). They were divided into 3 groups: the 20 normotensive pregnant women (group 1); 32 women with mild pre-eclampsia (group 2); and 21 women with severe pre-eclampsia (group 3). The plasma levels of adiponectin and leptin are measured simultaneously and their correlation and balance were evaluated by enzyme-linked immunosorbent assay.
RESULTS: Compared with controls, levels of adiponectin were significantly lower in women with mild or severe PE (P<0.01 for both groups) whereas levels of leptin were significantly higher in women with mild or severe PE (P<0.05 and P<0.01, respectively). There was a negative correlation between plasma levels of adiponectin and leptin in pre-eclamptic women (r=-0.76, P<0.01). Moreover, the adiponectin level to leptin level ratio was significantly lower in pre-eclamptic women than that in healthy controls (P<0.01). In the pre-eclamptic women serum levels of triglycerides, total cholesterol and low-density lipoprotein cholesterol were significantly increased (P<0.01 for all), while high-density lipoprotein cholesterol was significantly decreased compared to levels in normotensive pregnant women (P<0.01).
CONCLUSIONS: These findings suggest that there is an imbalance between adiponectin and leptin in the plasma of pre-eclamptic women. Reduced adiponectin and elevated leptin levels may be involved in the pathogenesis of PE and associated with the development of severe disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17585917     DOI: 10.1016/j.ijgo.2007.04.021

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  21 in total

1.  Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study.

Authors:  Maria Dalamaga; Sindhu K Srinivas; Michal A Elovitz; John Chamberland; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

2.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

3.  Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Sun Kwon Kim; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Pooja Mittal; Zhong Dong; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Perinat Med       Date:  2010-05       Impact factor: 1.901

4.  Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with Type 2 diabetes.

Authors:  J Zaletel; D Pongrac Barlovic; J Prezelj
Journal:  J Endocrinol Invest       Date:  2010-02-05       Impact factor: 4.256

5.  The influence of overweight and obesity on maternal soluble fms-like tyrosine kinase 1 and its relationship with leptin during pregnancy.

Authors:  Jennifer K Straughen; Dawn P Misra; Pawan Kumar; Vinod K Misra
Journal:  Reprod Sci       Date:  2012-08-07       Impact factor: 3.060

6.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

7.  Maternal visfatin concentration in normal pregnancy.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

8.  Helicobacter pylori seropositivity and its relationship with serum malondialdehyde and lipid profile in preeclampsia.

Authors:  Hulya Aksoy; Asuman Ozkan; Ferda Aktas; Bunyamin Borekci
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

9.  Comparison of serum maternal adiponectin concentrations in women with isolated intrauterine growth retardation and intrauterine growth retardation concomitant with pre-eclampsia.

Authors:  Barış Büke; Hasan Onur Topçu; Yaprak Engin-Üstün; Nuri Danışman
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

10.  Maternal serum adiponectin multimers in patients with a small-for-gestational-age newborn.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Offer Erez; Pooja Mittal; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Percy Pacora; Lami Yeo; Francesca Gotsch; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.